Tuesday, 18 October 2022

Home » » Active Pharmaceutical Ingredients Market Size, Growth, Demands Outlook and Forecasts to 2030

Active Pharmaceutical Ingredients Market Size, Growth, Demands Outlook and Forecasts to 2030

No comments

 According to the research report, the global activepharmaceutical ingredients market size is expected to touch USD 355.94 Billion by 2030, from USD 191.19 Billion in 2021, growing with a significant CAGR of 7.1% from 2022 to 2030. 


Active Pharmaceutical Ingredient Market Size 2020 to 2030

The active pharmaceutical ingredients market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global active pharmaceutical ingredients market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global active pharmaceutical ingredients market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global active pharmaceutical ingredients market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link https://www.precedenceresearch.com/sample/1035

 Report Scope of the Active Pharmaceutical Ingredients Market

Report CoverageDetails
Market SizeUSD 355.94 Billion by 2030
Growth RateCAGR of 7.1% from 2022 to 2030
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2021
Forecast Period2022 to 2030
Segments CoveredType of Manufacturer, Type, Type of Synthesis, Application, Regional Outlook

This study covers a detailed segmentation of the global active pharmaceutical ingredients market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global active pharmaceutical ingredients market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Albemarle Corporation
  • AurobindoPharma
  • Reddy’s Laboratories Ltd.
  • AbbVieInc
  • Teva Pharmaceutical Industries Ltd
  • Mylan N.V.
  • CiplaInc
  • BoehringerIngelheim International GmbH
  • Merck & Co., Inc
  • Sun Pharmaceutical Industries Ltd
  • Bristol-Myers Squibb Company

Market Segmentation

 By Type of Manufacturer

  • Merchant APIs
    • By Type
      • Generic APIs
      • Innovative APIs
    • By Type of Synthesis
      • Biotech
      • Synthetic
  • Captive APIs

By Type

  • Generic APIs
  • Innovative APIs

By Type of Synthesis

  • Biotech APIs Market, By Type
    • By Type
      • Generic APIs
      • Innovative APIs
    • By Product
      • Monoclonal Antibodies
      • Hormones
      • Cytokines
      • Recombinant Proteins
      • Therapeutic Enzymes
      • Vaccines
      • Blood Factors
  • Synthetic
    • By Type
      • Generic APIs
      • Innovative APIs

By Type of Drug

  • Prescription Drugs
  • Over-the-counter Drugs

By Application

  • Anti-infective
  • Orthopedic
  • Pulmonology
  • Gastroenterology
  • Endocrinology
  • Cardiology
  • Oncology
  • CNS & Neurology
  • Nephrology
  • Ophthalmology
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

Research Methodology

The research methodology adopted by analysts for compiling the global active pharmaceutical ingredients market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global active pharmaceutical ingredients market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Active Pharmaceutical Ingredient Market, By Type of Manufacturer

7.1. Active Pharmaceutical Ingredient Market, by Type of Manufacturer Type, 2021-2030
7.1.1. Merchant APIs
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Captive APIs
7.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Active Pharmaceutical Ingredient Market, By Type

8.1. Active Pharmaceutical Ingredient Market, by Type, 2021-2030
8.1.1. Generic APIs
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Innovative APIs
8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Active Pharmaceutical Ingredient Market, By Type of Synthesis

9.1. Active Pharmaceutical Ingredient Market, by Type of Synthesis, 2021-2030
9.1.1. Biotech (Recombinant Proteins, Monoclonal Antibodies, Vaccines)
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Synthetic
9.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Active Pharmaceutical Ingredient Market, By Application

10.1. Active Pharmaceutical Ingredient Market, by Application, 2021-2030
10.1.1. Orthopedic
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Pulmonology
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Gastroenterology
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Endocrinology
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Cardiology
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Oncology
10.1.6.1. Market Revenue and Forecast (2019-2030)
10.1.7. CNS & Neurology
10.1.7.1. Market Revenue and Forecast (2019-2030)
10.1.8. Nephrology
10.1.8.1. Market Revenue and Forecast (2019-2030)
10.1.9. Other
10.1.9.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Active Pharmaceutical Ingredient Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.1.2. Market Revenue and Forecast, by Type (2019-2030)
11.1.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.1.4. Market Revenue and Forecast, by Application (2019-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Type (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.1.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.1.6.2. Market Revenue and Forecast, by Type (2019-2030)
11.1.6.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.1.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.2.2. Market Revenue and Forecast, by Type (2019-2030)
11.2.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.2.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Type (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.2.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Type (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.2.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Type (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.2.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.2.8.2. Market Revenue and Forecast, by Type (2019-2030)
11.2.8.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.2.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.3.2. Market Revenue and Forecast, by Type (2019-2030)
11.3.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.3.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Type (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.3.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Type (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.3.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Type (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.3.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.3.8.2. Market Revenue and Forecast, by Type (2019-2030)
11.3.8.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.3.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.4.2. Market Revenue and Forecast, by Type (2019-2030)
11.4.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.4.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Type (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.4.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Type (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.4.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Type (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.4.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.4.8.2. Market Revenue and Forecast, by Type (2019-2030)
11.4.8.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.4.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.5.2. Market Revenue and Forecast, by Type (2019-2030)
11.5.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Type (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.5.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type of Manufacturer (2019-2030)
11.5.6.2. Market Revenue and Forecast, by Type (2019-2030)
11.5.6.3. Market Revenue and Forecast, by Type of Synthesis (2019-2030)
11.5.6.4. Market Revenue and Forecast, by Application (2019-2030)

Chapter 12. Company Profiles

12.1. Albemarle Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AurobindoPharma
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Dr. Reddy’s Laboratories Ltd.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AbbVieInc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Teva Pharmaceutical Industries Ltd
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Mylan N.V.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CiplaInc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. BoehringerIngelheim International GmbH
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Merck & Co., Inc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Sun Pharmaceutical Industries Ltd
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Bristol-Myers Squibb Company
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Share:

0 comments:

Post a Comment